Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eckert & Ziegler SEEKZRF 77 EV-to-OCF is 15.42 as of Sep. 01, 2026, which is 4% below its 10-year median of 16.12. GuruFocus rates EKZRF with a GF Score™ of 77/100 and a GF Value™ of $18.72 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 851 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks worse than 65.92% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Eckert & Ziegler SE's Enterprise Value is $886.2 Mil.
Eckert & Ziegler SE's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $57.5 Mil. Therefore, Eckert & Ziegler SE's EV-to-OCF for today is 15.42.
The historical rank and industry rank for Eckert & Ziegler SE's EV-to-OCF or its related term are showing as below:
EKZRF'
s EV-to-OCF Range Over the Past 10 Years
Min: 3.93 Med: 16.12 Max: 62.48
Current: 15.45
During the past 13 years, the highest EV-to-OCF of Eckert & Ziegler SE was 62.48. The lowest was 3.93. And the median was 16.12.
EKZRF's EV-to-OCF is ranked worse than 65.92% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.91
vs EKZRF: 15.45
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eckert & Ziegler SE (OTCPK:EKZRF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eckert & Ziegler SE's PE Ratio (TTM) for today is calculated as:
Eckert & Ziegler SE's share price for today is $15.57.
Eckert & Ziegler SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.920.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Eckert & Ziegler SE EV-to-OCF Related Terms
Eckert & Ziegler SE EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Eckert & Ziegler SE's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's EV-to-OCF falls into.
Eckert & Ziegler SE's current Enterprise Value is $886.2 Mil.
Eckert & Ziegler SE's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $57.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eckert & Ziegler SE (EKZRF) has a EV-to-OCF of 15.42 as of Sep. 01, 2026. This is near median its historical median of 16.12. Over the past decade, Eckert & Ziegler SE's EV-to-OCF has ranged from 3.93 to 62.48. According to the industry distribution chart, Eckert & Ziegler SE ranks #561 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 65.9%.
Is Eckert & Ziegler SE's EV-to-OCF too high?
Eckert & Ziegler SE's current EV-to-OCF of 15.42 is near median its 10-year median of 16.12. Over the past 10 years, this metric has ranged from a low of 3.93 to a high of 62.48. The Medical Devices & Instruments industry median EV-to-OCF is 7.91. Eckert & Ziegler SE's value of 15.42 is 94.9% above this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #561 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #561 out of 851 companies for EV-to-OCF. This places Eckert & Ziegler SE in the lower half of its industry. The industry median EV-to-OCF is 7.91. Eckert & Ziegler SE's value of 15.42 is 94.9% above this benchmark. Historically, Eckert & Ziegler SE's own EV-to-OCF has ranged from 3.93 to 62.48 over the past decade. While the company's 10-year median is 16.12 vs. the industry median of 7.91, Eckert & Ziegler SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.91, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current EV-to-OCF of 15.42 is 94.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current EV-to-OCF is 15.42, which is near median its own 10-year median of 16.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (EKZRF) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.72, compared to a current price of $15.57 — trading 16.8% below its estimated fair value. The current EV-to-OCF is 15.42, which is near median its 10-year median of 16.12 and 94.9% above the Medical Devices & Instruments industry median of 7.91. Eckert & Ziegler SE's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Eckert & Ziegler SE (EKZRF), the current EV-to-OCF is 15.42 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (EKZRF) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of $15.57 is trading 16.8% below its estimated GF Value™ of $18.72.
GuruFocus considers Eckert & Ziegler SE to be Modestly Undervalued.
Key valuation signals for EKZRF:
EV-to-OCF: 15.42 (near median its 10-year median of 16.12)
GF Value™: $18.72 vs. price of $15.57 (16.8% below fair value)
Industry Position: 94.9% above the Medical Devices & Instruments median (#561 of 851)
No single metric tells the full story. See the EKZRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
77GF Score
Get the complete analysis for EKZRF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKZRF has been successfully added to your 
